TEE
AMPH icon

Tibra Equities Europe’s Amphastar Pharmaceuticals AMPH Stock Holding History

Tibra Equities Europe’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-31,500
Closed -$644K – 240
2019
Q1 		$644K Buy
+31,500
New +$706K 0.06% 235

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Tibra Equities Europe's AMPH Position: Q2 2019 in Review

Tibra Equities Europe sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2019, closing a stake of 31,500 shares — an estimated $644K sold.

Tibra Equities Europe first reported a position in AMPH in Q1 2019 and held it in 1 quarter. The position peaked at $644K in Q1 2019. 133 funds tracked by Wall St. Rank hold AMPH as of Q2 2019.

  • Tibra Equities Europe reported no remaining Amphastar Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Tibra Equities Europe sold 31,500 Amphastar Pharmaceuticals shares in Q2 2019, an estimated $644K.
  • Tibra Equities Europe first reported a position in Amphastar Pharmaceuticals in Q1 2019 and held it in 1 quarter.
  • Tibra Equities Europe's Amphastar Pharmaceuticals position peaked at $644K in Q1 2019.
  • 133 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2019.

Based on Tibra Equities Europe's 13F filing for Q2 2019, filed 1 Aug 2019.